| Financial Year |
March 31 2023 |
| Monetary Funds |
668,184,898.14 |
| Held-for-trading Financial Assets |
637,020.57 |
| Notes Receivable |
36,765,466.40 |
| Accounts Receivable |
823,374,173.92 |
| Advances to Suppliers |
14,370,514.58 |
| Other Receivables |
6,541,515.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
508,275,542.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,606,810.02 |
| Total Current Assets |
2,308,654,252.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,226,599.02 |
| Investment Properties |
38,978,194.70 |
| Fixed Assetes |
361,019,543.34 |
| Under-construction Projects |
41,496,312.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,744,722.33 |
| R&D expenses |
-- |
| Goodwill |
3,040,666.32 |
| Long-Term Deferred and Prepaid Expenses |
8,658,538.35 |
| Deferred Income Tax Assets |
11,026,955.32 |
| Other Non-Current Assets |
20,905,970.21 |
| Sub-Total of Non-Current Assets |
690,769,165.10 |
| Total Assets |
2,999,423,417.60 |
| Short-Term Loans |
6,024,287.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,824,918.44 |
| Accounts Payable |
448,050,683.46 |
| Accounts Received In Advance |
396,272.15 |
| Employee Compensation Payable |
5,985,507.80 |
| Taxes Payable |
13,198,823.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,690,688.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,007,673.03 |
| Other Current Liabilities |
1,802,809.83 |
| Sub-Total of Current Liabilities |
648,108,601.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,287,174.48 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,527,769.49 |
| Total Liabilities |
686,636,370.64 |
| Paid-In Capital(Or Share Stock) |
385,161,857.00 |
| Capital Surplus |
1,785,648,163.56 |
| Surplus Reserve |
42,167,837.69 |
| LESS:Treasury Stock |
10,564,000.00 |
| Undistributed Profits |
72,714,966.09 |
| Minority Stockholder's Interest |
37,658,222.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,275,128,824.34 |
| Owner's Equity（Stockholder's Equity） |
2,312,787,046.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,999,423,417.60 |
